PLATINUM INVESTMENT MANAGEMENT LTD - ACCELERON PHARMA INC ownership

ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 174 filers reported holding ACCELERON PHARMA INC in Q1 2019. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.

Quarter-by-quarter ownership
PLATINUM INVESTMENT MANAGEMENT LTD ownership history of ACCELERON PHARMA INC
ValueSharesWeighting
Q3 2021$2,387,000
+37.1%
13,8720.0%0.07%
+67.5%
Q2 2021$1,741,000
-7.4%
13,8720.0%0.04%
-4.8%
Q1 2021$1,881,000
+6.0%
13,8720.0%0.04%
+2.4%
Q4 2020$1,775,000
+13.7%
13,8720.0%0.04%
+5.1%
Q3 2020$1,561,000
-17.2%
13,872
-29.9%
0.04%
-9.3%
Q2 2020$1,886,000
-8.3%
19,800
-13.5%
0.04%
-17.3%
Q1 2020$2,057,000
-24.7%
22,887
-55.5%
0.05%
-3.7%
Q4 2019$2,730,000
+34.2%
51,4890.0%0.05%
+17.4%
Q3 2019$2,034,000
-3.8%
51,4890.0%0.05%
-8.0%
Q2 2019$2,115,000
-11.8%
51,4890.0%0.05%
-10.7%
Q1 2019$2,398,000
+7.0%
51,4890.0%0.06%
-26.3%
Q4 2018$2,242,000
-23.9%
51,4890.0%0.08%
-9.5%
Q3 2018$2,947,000
+3.8%
51,489
-12.0%
0.08%
+25.4%
Q2 2018$2,838,000
+24.1%
58,5000.0%0.07%
+4.7%
Q1 2018$2,287,000
-7.9%
58,5000.0%0.06%
-3.0%
Q4 2017$2,482,000
+13.7%
58,5000.0%0.07%
+20.0%
Q3 2017$2,183,000
+4.2%
58,500
-15.2%
0.06%
-3.5%
Q2 2017$2,096,000
+81.6%
69,000
+58.3%
0.06%
+78.1%
Q1 2017$1,154,00043,6000.03%
Other shareholders
ACCELERON PHARMA INC shareholders Q1 2019
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,449,300$59,537,000,0006.61%
Foresite Capital Management II, LLC 188,602$7,748,0004.36%
Foresite Capital Management III, LLC 254,923$10,472,0003.43%
Artal Group S.A. 1,500,000$61,620,0002.49%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 1,305,174$53,617,0001.93%
Asymmetry Capital Management, L.P. 82,473$3,388,0001.84%
QVT Financial LP 190,977$7,845,0001.66%
SECTORAL ASSET MANAGEMENT INC 269,396$11,067,0001.32%
Sofinnova Investments, Inc. 241,043$9,902,0000.91%
Novo Holdings A/S 119,708$4,918,0000.69%
View complete list of ACCELERON PHARMA INC shareholders